Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Cullin7: a new gene involved in liver carcinogenesis related to metabolic syndrome.

Paradis V, Albuquerque M, Mebarki M, Hernandez L, Zalinski S, Quentin S, Belghiti J, Soulier J, Bedossa P.

Gut. 2013 Jun;62(6):911-9. doi: 10.1136/gutjnl-2012-302091. Epub 2012 Sep 1.

PMID:
22942238
2.

Molecular cytogenetic evaluation of virus-associated and non-viral hepatocellular carcinoma: analysis of 26 carcinomas and 12 concurrent dysplasias.

Zondervan PE, Wink J, Alers JC, IJzermans JN, Schalm SW, de Man RA, van Dekken H.

J Pathol. 2000 Oct;192(2):207-15.

PMID:
11004697
3.
4.

The PNPLA3 rs738409 148M/M genotype is a risk factor for liver cancer in alcoholic cirrhosis but shows no or weak association in hepatitis C cirrhosis.

Nischalke HD, Berger C, Luda C, Berg T, Müller T, Grünhage F, Lammert F, Coenen M, Krämer B, Körner C, Vidovic N, Oldenburg J, Nattermann J, Sauerbruch T, Spengler U.

PLoS One. 2011;6(11):e27087. doi: 10.1371/journal.pone.0027087. Epub 2011 Nov 7.

5.

Genetic evaluation of the dysplasia-carcinoma sequence in chronic viral liver disease: a detailed analysis of two cases and a review of the literature.

van Dekken H, Wink J, Alers JC, de Man RA, IJzermans JN, Zondervan PE.

Acta Histochem. 2003;105(1):29-41.

PMID:
12666986
6.

A novel genetic marker of liver disease aetiology in hepatocellular carcinoma: culling the metabolic syndrome.

Brunt EM.

Gut. 2013 Jun;62(6):808-9. doi: 10.1136/gutjnl-2012-303451. Epub 2012 Oct 18. No abstract available.

PMID:
23081686
7.

Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression.

Mas VR, Maluf DG, Stravitz R, Dumur CI, Clark B, Rodgers C, Ferreira-Gonzalez A, Fisher RA.

Liver Transpl. 2004 May;10(5):607-20.

9.
10.

Targeted disruption of S100P suppresses tumor cell growth by down-regulation of cyclin D1 and CDK2 in human hepatocellular carcinoma.

Kim JK, Jung KH, Noh JH, Eun JW, Bae HJ, Xie HJ, Ahn YM, Ryu JC, Park WS, Lee JY, Nam SW.

Int J Oncol. 2009 Dec;35(6):1257-64.

PMID:
19885547
11.

Cyclins and cyclin-dependent kinases: comparative study of hepatocellular carcinoma versus cirrhosis.

Masaki T, Shiratori Y, Rengifo W, Igarashi K, Yamagata M, Kurokohchi K, Uchida N, Miyauchi Y, Yoshiji H, Watanabe S, Omata M, Kuriyama S.

Hepatology. 2003 Mar;37(3):534-43.

PMID:
12601350
12.

Marked genetic similarities between hepatitis B virus-positive and hepatitis C virus-positive hepatocellular carcinomas.

Tornillo L, Carafa V, Richter J, Sauter G, Moch H, Minola E, Gambacorta M, Bianchi L, Vecchione R, Terracciano LM.

J Pathol. 2000 Nov;192(3):307-12.

PMID:
11054713
13.
14.

Co-expression of XIAP and cyclin D1 complex correlates with a poor prognosis in patients with hepatocellular carcinoma.

Che Y, Ye F, Xu R, Qing H, Wang X, Yin F, Cui M, Burstein D, Jiang B, Zhang DY.

Am J Pathol. 2012 May;180(5):1798-807. doi: 10.1016/j.ajpath.2012.01.016. Epub 2012 Mar 17.

PMID:
22429965
15.

Activation of fetal promoters of insulinlike growth factors II gene in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.

Nardone G, Romano M, Calabrò A, Pedone PV, de Sio I, Persico M, Budillon G, Bruni CB, Riccio A, Zarrilli R.

Hepatology. 1996 Jun;23(6):1304-12.

PMID:
8675143
16.

Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.

Ikeguchi M, Hirooka Y, Kaibara N.

Cancer. 2002 Nov 1;95(9):1938-45.

17.

A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.

Llovet JM, Chen Y, Wurmbach E, Roayaie S, Fiel MI, Schwartz M, Thung SN, Khitrov G, Zhang W, Villanueva A, Battiston C, Mazzaferro V, Bruix J, Waxman S, Friedman SL.

Gastroenterology. 2006 Dec;131(6):1758-67. Epub 2006 Sep 19.

PMID:
17087938
18.

Hepatic expression of the proliferative marker Ki-67 and p53 protein in HBV or HCV cirrhosis in relation to dysplastic liver cell changes and hepatocellular carcinoma.

Koskinas J, Petraki K, Kavantzas N, Rapti I, Kountouras D, Hadziyannis S.

J Viral Hepat. 2005 Nov;12(6):635-41.

PMID:
16255765
19.

Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.

Masaki T, Tokuda M, Yoshida S, Nakai S, Morishita A, Uchida N, Funaki T, Kita Y, Funakoshi F, Nonomura T, Himoto T, Deguchi A, Kimura Y, Izuishi K, Wakabayashi H, Usuki H, Yoshiji H, Watanabe S, Kurokohchi K, Kuriyama S.

Int J Oncol. 2005 Mar;26(3):661-71.

PMID:
15703821
20.

Expression of p53 protein in liver and sera of patients with liver fibrosis, liver cirrhosis or hepatocellular carcinoma associated with chronic HCV infection.

Attallah AM, Shiha GE, Ismail H, Mansy SE, El-Sherbiny R, El-Dosoky I.

Clin Biochem. 2009 Apr;42(6):455-61. doi: 10.1016/j.clinbiochem.2008.11.004. Epub 2008 Nov 27.

PMID:
19063876

Supplemental Content

Support Center